Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd (600671.SS)
CNY 14.62
(5.03%)
CNY 14.62
(5.03%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 7.23 Million CNY | -3.1% |
| 2022 | 7.46 Million CNY | 63.98% |
| 2021 | 4.55 Million CNY | -12.92% |
| 2020 | 5.22 Million CNY | -85.87% |
| 2019 | 37 Million CNY | 469.23% |
| 2018 | 6.5 Million CNY | -85.87% |
| 2017 | 46 Million CNY | 0.0% |
| 2016 | - CNY | 0.0% |
| 2015 | - CNY | 0.0% |
| 2014 | - CNY | 0.0% |
| 2013 | - CNY | 0.0% |
| 2012 | - CNY | 0.0% |
| 2011 | - CNY | 0.0% |
| 2010 | - CNY | 0.0% |
| 2009 | - CNY | 0.0% |
| 2008 | - CNY | 0.0% |
| 2007 | - CNY | 0.0% |
| 2006 | - CNY | 0.0% |
| 2005 | - CNY | 0.0% |
| 2004 | - CNY | 0.0% |
| 2003 | - CNY | 0.0% |
| 2002 | - CNY | 0.0% |
| 2001 | - CNY | 0.0% |
| 2000 | - CNY | -100.0% |
| 1999 | 100 Thousand CNY | -50.0% |
| 1998 | 200 Thousand CNY | 100.0% |
| 1997 | 100 Thousand CNY | -94.76% |
| 1996 | 1.9 Million CNY | 1699.04% |
| 1995 | 106.08 Thousand CNY | 0.0% |
| 1994 | - CNY | -100.0% |
| 1993 | 4.34 Million CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | - CNY | 0.0% |
| 2024 Q2 | 6.29 Million CNY | 0.0% |
| 2024 Q1 | 6.38 Million CNY | 0.0% |
| 2023 Q4 | 7.23 Million CNY | 8.65% |
| 2023 Q1 | 7.59 Million CNY | 1.75% |
| 2023 Q2 | 6.64 Million CNY | -12.51% |
| 2023 FY | 7.23 Million CNY | -3.1% |
| 2023 Q3 | 6.65 Million CNY | 0.18% |
| 2022 Q4 | 7.46 Million CNY | 56.94% |
| 2022 FY | 7.46 Million CNY | 63.98% |
| 2022 Q1 | 4.64 Million CNY | 2.04% |
| 2022 Q2 | 4.96 Million CNY | 6.85% |
| 2022 Q3 | 4.75 Million CNY | -4.17% |
| 2021 Q4 | 4.55 Million CNY | 0.0% |
| 2021 Q1 | - CNY | 0.0% |
| 2021 FY | 4.55 Million CNY | -12.92% |
| 2021 Q2 | - CNY | 0.0% |
| 2021 Q3 | - CNY | 0.0% |
| 2020 FY | 5.22 Million CNY | -85.87% |
| 2020 Q1 | 50 Million CNY | 35.14% |
| 2020 Q2 | 50 Million CNY | 0.0% |
| 2020 Q3 | 31 Million CNY | -38.0% |
| 2020 Q4 | - CNY | -100.0% |
| 2019 Q1 | 13 Million CNY | 100.0% |
| 2019 Q4 | 37 Million CNY | -26.0% |
| 2019 FY | 37 Million CNY | 469.23% |
| 2019 Q3 | 50 Million CNY | 51.52% |
| 2019 Q2 | 33 Million CNY | 153.85% |
| 2018 Q2 | 46 Million CNY | 0.0% |
| 2018 Q1 | 46 Million CNY | 0.0% |
| 2018 Q4 | 6.5 Million CNY | -85.87% |
| 2018 FY | 6.5 Million CNY | -85.87% |
| 2018 Q3 | 46 Million CNY | 0.0% |
| 2017 Q2 | 50 Million CNY | 0.0% |
| 2017 Q4 | 46 Million CNY | -8.0% |
| 2017 FY | 46 Million CNY | 0.0% |
| 2017 Q1 | - CNY | 0.0% |
| 2017 Q3 | 50 Million CNY | 0.0% |
| 2016 Q1 | - CNY | 0.0% |
| 2016 Q2 | - CNY | 0.0% |
| 2016 Q4 | - CNY | 0.0% |
| 2016 Q3 | - CNY | 0.0% |
| 2016 FY | - CNY | 0.0% |
| 2015 FY | - CNY | 0.0% |
| 2015 Q2 | - CNY | 0.0% |
| 2015 Q3 | - CNY | 0.0% |
| 2015 Q4 | - CNY | 0.0% |
| 2015 Q1 | - CNY | 0.0% |
| 2014 Q1 | - CNY | 0.0% |
| 2014 Q2 | - CNY | 0.0% |
| 2014 Q3 | - CNY | 0.0% |
| 2014 FY | - CNY | 0.0% |
| 2014 Q4 | - CNY | 0.0% |
| 2013 Q3 | - CNY | 0.0% |
| 2013 Q4 | - CNY | 0.0% |
| 2013 FY | - CNY | 0.0% |
| 2013 Q1 | - CNY | 0.0% |
| 2013 Q2 | - CNY | 0.0% |
| 2012 FY | - CNY | 0.0% |
| 2012 Q1 | - CNY | 0.0% |
| 2012 Q4 | - CNY | 0.0% |
| 2012 Q2 | - CNY | 0.0% |
| 2012 Q3 | - CNY | 0.0% |
| 2011 FY | - CNY | 0.0% |
| 2011 Q3 | - CNY | 0.0% |
| 2011 Q2 | - CNY | 0.0% |
| 2011 Q4 | - CNY | 0.0% |
| 2011 Q1 | - CNY | 0.0% |
| 2010 FY | - CNY | 0.0% |
| 2010 Q2 | - CNY | 0.0% |
| 2010 Q3 | - CNY | 0.0% |
| 2010 Q4 | - CNY | 0.0% |
| 2010 Q1 | - CNY | 0.0% |
| 2009 Q2 | - CNY | 0.0% |
| 2009 Q3 | - CNY | 0.0% |
| 2009 Q4 | - CNY | 0.0% |
| 2009 FY | - CNY | 0.0% |
| 2009 Q1 | - CNY | 0.0% |
| 2008 Q3 | - CNY | 0.0% |
| 2008 Q1 | - CNY | 0.0% |
| 2008 Q4 | - CNY | 0.0% |
| 2008 FY | - CNY | 0.0% |
| 2008 Q2 | - CNY | 0.0% |
| 2007 Q4 | - CNY | -100.0% |
| 2007 Q3 | 800 Thousand CNY | 0.0% |
| 2007 FY | - CNY | 0.0% |
| 2007 Q2 | - CNY | 0.0% |
| 2007 Q1 | - CNY | 0.0% |
| 2006 Q3 | - CNY | 0.0% |
| 2006 Q1 | - CNY | 0.0% |
| 2006 Q4 | - CNY | 0.0% |
| 2006 FY | - CNY | 0.0% |
| 2006 Q2 | - CNY | 0.0% |
| 2005 Q4 | - CNY | 0.0% |
| 2005 FY | - CNY | 0.0% |
| 2005 Q3 | - CNY | 0.0% |
| 2005 Q2 | - CNY | -100.0% |
| 2005 Q1 | 800 Thousand CNY | 0.0% |
| 2004 Q1 | - CNY | 0.0% |
| 2004 Q2 | 800 Thousand CNY | 0.0% |
| 2004 Q3 | 800 Thousand CNY | 0.0% |
| 2004 FY | - CNY | 0.0% |
| 2004 Q4 | - CNY | -100.0% |
| 2003 Q4 | - CNY | 0.0% |
| 2003 Q1 | - CNY | 0.0% |
| 2003 Q3 | - CNY | 0.0% |
| 2003 Q2 | - CNY | 0.0% |
| 2003 FY | - CNY | 0.0% |
| 2002 FY | - CNY | 0.0% |
| 2002 Q3 | - CNY | 0.0% |
| 2002 Q2 | - CNY | 0.0% |
| 2002 Q1 | - CNY | 0.0% |
| 2002 Q4 | - CNY | 0.0% |
| 2001 Q4 | - CNY | 0.0% |
| 2001 Q2 | - CNY | 0.0% |
| 2001 FY | - CNY | 0.0% |
| 2000 Q4 | - CNY | 0.0% |
| 2000 FY | - CNY | -100.0% |
| 2000 Q2 | 100 Thousand CNY | 0.0% |
| 1999 FY | 100 Thousand CNY | -50.0% |
| 1999 Q2 | 100 Thousand CNY | 0.0% |
| 1999 Q4 | 100 Thousand CNY | 0.0% |
| 1998 FY | 200 Thousand CNY | 100.0% |
| 1998 Q4 | 200 Thousand CNY | 0.0% |
| 1998 Q2 | 100 Thousand CNY | 0.0% |
| 1997 Q4 | 100 Thousand CNY | 0.0% |
| 1997 Q2 | - CNY | 0.0% |
| 1997 FY | 100 Thousand CNY | -94.76% |
| 1996 FY | 1.9 Million CNY | 1699.04% |
| 1996 Q4 | 1.9 Million CNY | 0.0% |
| 1996 Q2 | - CNY | 0.0% |
| 1995 FY | 106.08 Thousand CNY | 0.0% |
| 1995 Q4 | 106.08 Thousand CNY | 0.0% |
| 1995 Q2 | - CNY | 0.0% |
| 1994 FY | - CNY | -100.0% |
| 1994 Q2 | - CNY | 0.0% |
| 1994 Q4 | - CNY | 0.0% |
| 1993 FY | 4.34 Million CNY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | 75.17 Million CNY | 90.381% |
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 35.44 Million CNY | 79.596% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 305.75 Million CNY | 97.635% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 170.1 Million CNY | 95.749% |
| Aurora Optoelectronics Co.,Ltd. | 13.33 Million CNY | 45.766% |
| NanJing Pharmaceutical Company Limited | 2.11 Billion CNY | 99.659% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 39.11 Million CNY | 81.51% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | - CNY | -Infinity% |